WuXi Biologics (Cayman) Inc. (HKG:2269)
Hong Kong · Delayed Price · Currency is HKD 35.58
-0.14 (-0.39%)
Apr 20, 2026, 4:08 PM HKT
WuXi Biologics Market Cap
WuXi Biologics has a market cap or net worth of 147.8 billion as of April 20, 2026. Its market cap has increased by 36.89% in one year.
Market Cap
147.80B
Enterprise Value
140.19B
Revenue
24.25B
Ranking
n/a
PE Ratio
27.66
Stock Price
35.58
Market Cap Chart
Since June 13, 2017, WuXi Biologics's market cap has increased from 32.04B to 147.80B, an increase of 361.32%. That is a compound annual growth rate of 18.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 147.80B | 13.73% |
| Dec 31, 2025 | 129.96B | 80.25% |
| Dec 31, 2024 | 72.10B | -42.32% |
| Dec 29, 2023 | 124.99B | -50.53% |
| Dec 30, 2022 | 252.68B | -35.37% |
| Dec 31, 2021 | 390.94B | -6.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 13, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 281.22B |
| Innovent Biologics | 158.77B |
| Akeso | 139.09B |
| Sichuan Kelun-Biotech Biopharmaceutical | 121.26B |
| Sino Biopharmaceutical | 107.21B |
| RemeGen | 85.82B |
| 3SBio | 63.09B |
| Shanghai Junshi Biosciences | 47.19B |